Skip to main content
Premium Trial:

Request an Annual Quote

Marina Stock Moved to Over-the-Counter Markets

Premium

Marina Biotech this week announced that its stock has begun trading on the over-the-counter markets after the company was unable to meet the Nasdaq's listing requirements.

"I and our board of directors have decided, at this point, that the company is not in a position to meet the listing standards of the Nasdaq stock market,” Marina President and CEO Michael French said in a statement. “By utilizing the strengths of the OTC markets, we believe we can be in a position in the future to return to a national securities exchange if we so choose."

Marina failed to meet the Nasdaq's minimum $1 bid price. As of Thursday morning, the company's shares were trading at around $0.49 each.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.